ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 861 filers reported holding ISHARES TR in Q4 2020. The put-call ratio across all filers is 1.57 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,357 | -3.7% | 191 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $24,249 | -49.4% | 191 | -48.5% | 0.00% | -50.0% |
| Q1 2023 | $47,918 | -1.6% | 371 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $48,709 | +13.3% | 371 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $43,000 | -2.3% | 371 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $44,000 | -8.3% | 371 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $48,000 | -57.9% | 371 | -50.0% | 0.00% | 0.0% |
| Q4 2021 | $114,000 | +90.0% | 742 | +100.0% | 0.00% | 0.0% |
| Q3 2021 | $60,000 | +25.0% | 371 | +25.3% | 0.00% | +100.0% |
| Q2 2021 | $48,000 | -27.3% | 296 | -32.1% | 0.00% | -50.0% |
| Q1 2021 | $66,000 | +20.0% | 436 | +19.5% | 0.00% | 0.0% |
| Q4 2020 | $55,000 | +12.2% | 365 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $49,000 | +63.3% | 365 | +62.2% | 0.00% | +100.0% |
| Q2 2020 | $30,000 | -23.1% | 225 | -38.0% | 0.00% | -50.0% |
| Q1 2020 | $39,000 | +56.0% | 363 | +61.3% | 0.00% | +100.0% |
| Q2 2018 | $25,000 | – | 225 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Elliott Investment Management L.P. | 4,617,600 | $564,686,304 | 4.37% |
| BOULDER HILL CAPITAL MANAGEMENT LP | 57,250 | $7,001,103 | 4.35% |
| DAFNA Capital Management LLC | 102,500 | $12,534,725 | 3.90% |
| Michelson Medical Research Foundation, Inc. | 43,395 | $5,306,775 | 3.58% |
| Rye Brook Capital LLC | 40,900 | $5,002 | 3.56% |
| Bronte Capital Management Pty Ltd. | 283,229 | $34,636,074 | 3.49% |
| FWL INVESTMENT MANAGEMENT, LLC | 39,504 | $4,830,944 | 3.24% |
| Alpha Family Trust | 34,568 | $4,227,321 | 3.22% |
| HARBOUR INVESTMENT MANAGEMENT LLC | 40,720 | $4,985,830 | 2.85% |
| CUMBERLAND ADVISORS INC | 51,490 | $6,296,712 | 2.79% |